⚖️Notice of Scope Ruling Applications in Antidumping and CVD Proceedings
The U.S. Department of Commerce (Commerce) received scope ruling applications, requesting that scope inquiries be conducted to determine whether identified products are covered by the scope of antidumping duty (AD) and/or countervailing duty (CVD) orders and that Commerce issue scope rulings pursuant to those inquiries. In accordance with Commerce's regulations, we are notifying the public of the filing of the scope ruling applications listed below in the month of July 2025.
Learn More⚡Revised Procedural Schedule for Bath County Pumped Storage Project
The Department of Energy reports an updated schedule for processing the Bath County Pumped Storage Project license application. Key milestones include the issuance of an acceptance letter and notice for environmental analysis, with specified target dates in late 2025. This notice reflects ongoing regulatory processes affecting multiple stakeholders involved in energy production.
Learn More🌊Jurisdictional Inquiry into Green Mountain Power's Hydroelectric Projects
The Federal Energy Regulatory Commission is investigating jurisdictional determinations for the Middlesex and Gorge Hydroelectric Projects in Vermont, following requests from the Vermont Department of Environmental Conservation. The inquiry focuses on potential navigability and its implications on project licensing and operational compliance. Comments and motions from interested parties are being solicited during this process.
Learn More⚡Rate Order SWPA-88 Increases Power Rates by 28.6%
The Acting Administrator of the Southwestern Power Administration (Southwestern) has confirmed, approved and placed into effect on an interim basis Rate Order No. SWPA-88 (Rate Order), which provides the rate schedule Wholesale Rates for Hydro Power and Energy at Robert D. Willis Hydropower Project (RDW-23). This new rate schedule for the Robert D. Willis Hydropower Project (Robert D. Willis) replaces the existing power rate under Rate Schedule RDW-15 which expires on September 30, 2025. Rate Schedule RDW-23 increases the annual wholesale power rate for Willis by 28.6 percent.
Learn More⚓Request for Comments on Maritime Service Obligation Renewal
MARAD invites public comments on its intention to request Office of Management and Budget (OMB) approval to renew an information collection in accordance with the Paperwork Reduction Act of 1995. The proposed collection OMB 2133-0510 (Request for Waiver of Service Obligation, Request for Deferment of Service Obligation, and Application for Review) is used to determine if waivers and deferments may be granted to graduates of the U.S. Merchant Marine Academy (USMMA) and State Maritime Academies (SMAs) who participated in the Student Incentive Payment (SIP) Program. There are no changes since the last renewal. MARAD is required to publish this notice in the Federal Register to obtain comments from the public and affected agencies.
Learn More📡FCC Regulation on Telecommunications Certification Body Compliance
The Federal Communications Commission (Commission) is correcting a final rule that appeared in the Federal Register on August 7, 2025. The document addressed requirements for all recognized telecommunication certification bodies (TCBs), test labs, and laboratory accreditation bodies to certify to the Commission that they are not owned by, controlled by, or subject to the direction of a prohibited entity and to report all equity or voting interests of 5% or greater by any entity. The document inadvertently included compliance dates for provisions that are delayed indefinitely and excluded a word in one section.
Learn More🏥Proposed Medicaid Information Collection Activities and Business Impact
On May 28, 2010, the Office of Management and Budget (OMB) issued Paperwork Reduction Act (PRA) guidance related to the "generic" clearance process. Generally, this is an expedited process by which agencies may obtain OMB's approval of collection of information requests that are "usually voluntary, low-burden, and uncontroversial collections," do not raise any substantive or policy issues, and do not require policy or methodological review. The process requires the submission of an overarching plan that defines the scope of the individual collections that would fall under its umbrella. This Federal Register notice seeks public comment on one or more of our collection of information requests that we believe are generic and fall within the scope of the umbrella. Interested persons are invited to submit comments regarding our burden estimates or any other aspect of this collection of information, including: the necessity and utility of the proposed information collection for the proper performance of the agency's functions, the accuracy of the estimated burden, ways to enhance the quality, utility and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden.
Learn More📋FDA's GRAS Notifications and Information Collection Overview
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Learn More🛢️ANR Pipeline Company Project Notice and Intervention Deadline
The Federal Energy Regulatory Commission has published a notice regarding ANR Pipeline Company’s request for authorization to construct new injection/withdrawal wells at the Goodwell Storage Field in Michigan. The project aims to restore lost deliverability and enhance reliability within the field, with a public participation process outlined for interested stakeholders.
Learn More🧪FDA Determines Patent Extension for ZUNVEYL Drug Product
The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for ZUNVEYL and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human drug product.
Learn More